Individualized prediction of survival benefit from postoperative radiotherapy for patients with malignant pleural mesothelioma

被引:1
|
作者
Wo, Yang [1 ,2 ,3 ]
Peng, Yizhou [1 ,2 ,3 ]
Wu, Zhigang [1 ,2 ,3 ]
Liu, Pengcheng [1 ,2 ,3 ]
Shang, Yan [1 ,2 ,3 ]
Shen, Xuxia [4 ,5 ,7 ]
Sun, Yihua [1 ,2 ,3 ,6 ]
机构
[1] Fudan Univ Shanghai Canc Ctr, State Key Lab Genet Engn, Shanghai, Peoples R China
[2] Fudan Univ, Dept Thorac Surg, Shanghai Canc Ctr, Shanghai, Peoples R China
[3] Fudan Univ, Inst Thorac Oncol, Shanghai, Peoples R China
[4] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China
[5] Fudan Univ, Dept Pathol, Shanghai Canc Ctr, Shanghai, Peoples R China
[6] Fudan Univ, Dept Thorac Surg, Shanghai Canc Ctr, 270 Dong An Rd, Shanghai 200032, Peoples R China
[7] Fudan Univ, Dept Pathol, Shanghai Canc Ctr, 270 Dong An Rd, Shanghai 200032, Peoples R China
来源
CANCER MEDICINE | 2023年 / 12卷 / 11期
基金
中国国家自然科学基金;
关键词
nomogram; prognostic factor; radiotherapy; SEER; STAGING PROJECT PROPOSALS; FORTHCOMING 8TH EDITION; MODULATED RADIATION-THERAPY; EXTRAPLEURAL PNEUMONECTOMY; IASLC MESOTHELIOMA; TNM CLASSIFICATION; HEMITHORACIC RADIOTHERAPY; PROGNOSTIC-FACTORS; DESCRIPTORS; PATTERNS;
D O I
10.1002/cam4.5955
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: The role of postoperative radiotherapy (PORT) in malignant pleural mesothelioma (MPM) remains controversial and the eighth edition TNM staging scheme for MPM has not been fully verified. We aimed to develop an individualized prediction model for identifying optimal candidates for PORT among MPM patients who received surgery plus chemotherapy and externally validate the performance of the new TNM staging scheme.Materials and Methods: Detailed characteristics of MPM patients during 2004-2015 were retrieved from SEER registries. Propensity score matching (PSM) was conducted to reduce disparities of baseline characteristics (age, sex, histologic type, stage, and type of surgery) between the PORT group and no-PORT group. A novel nomogram was constructed based on independent prognosticators identified by multivariate Cox regression model. The discriminatory performance and degree of calibration were evaluated. We stratified patients into different risk groups according to nomogram total scores and estimated the survival benefit of PORT in different subgroups in order to identify the optimal candidates.Results: We identified 596 MPM patients, among which 190 patients (31.9%) received PORT. PORT conferred significant survival benefit in the unmatched population, while there was no significant survival difference favoring PORT in the matched population. The C-index of the new TNM staging scheme was closed to 0.5, which represented a poor discriminatory ability. A novel nomogram was constructed based on clinicopathological factors, including age, sex, histology, and N stage. We stratified patients into three risk groups. Subgroup analyses indicated that PORT was beneficial for high-risk group (p = 0.003) rather than low-risk group (p = 0.965) and intermediate-risk group (p = 0.661).Conclusion: We established a novel predictive model, which could make individualized prediction of survival benefit of PORT for MPM and could compensate for weakness in TNM staging system.
引用
收藏
页码:12452 / 12461
页数:10
相关论文
共 50 条
  • [1] Survival Prediction Models for Patients with Malignant Pleural Mesothelioma After Adjuvant Radiotherapy
    Wang, Z.
    Li, V.
    Qi, X.
    MEDICAL PHYSICS, 2021, 48 (06)
  • [2] Log Odds of Positive Lymph Nodes Predicts Overall Survival and the Benefit of Postoperative Radiotherapy in Malignant Pleural Mesothelioma
    Wo, Y.
    Wang, Y.
    Lu, T.
    Jiao, W.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S265 - S265
  • [3] Survival benefit after radiotherapy for patients with malignant pleural mesothelioma: A propensity score-matched study
    Lian, Liyou
    Lei, Huijun
    Cheng, Shuwen
    Zheng, Rujie
    Yao, Hongxia
    Chen, Jinfei
    Chen, Tianhui
    MEDCOMM, 2023, 4 (02):
  • [5] Radiotherapy for malignant pleural mesothelioma
    Chapman, E.
    Berenstein, E. G.
    Dieguez, M.
    Ortiz, Z.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2006, (03):
  • [6] RADIOTHERAPY IN MALIGNANT PLEURAL MESOTHELIOMA
    McAleer, Mary Frances
    Tsao, Anne S.
    Liao, Zhongxing
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (02): : 326 - 337
  • [7] Forced Vital Capacity Is a Strong Predictor for Postoperative Survival of Patients with Malignant Pleural Mesothelioma
    Yotsukura, M.
    Yoshida, Y.
    Nakagawa, K.
    Watanabe, S-i.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S717 - S717
  • [8] Comorbidity, postoperative morbidity and survival in patients undergoing radical surgery for malignant pleural mesothelioma
    Infante, Maurizio
    Morenghi, Emanuela
    Bottoni, Edoardo
    Zucali, Paolo
    Rahal, Daoud
    Morlacchi, Andrea
    Ascolese, Anna Maria
    De Rose, Fiorenza
    Navarria, Pierina
    Crepaldi, Alessandro
    Testori, Alberto
    Voulaz, Emanuele
    Errico, Valentina
    Perrino, Matteo
    Scorsetti, Marta
    Chiti, Arturo
    Santoro, Armando
    Alloisio, Marco
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2016, 50 (06) : 1077 - 1082
  • [9] Radiotherapy for the treatment of malignant pleural mesothelioma
    de Perrot, Marc
    Wu, Licun
    Wu, Matthew
    Cho, B. C. John
    LANCET ONCOLOGY, 2017, 18 (09): : E532 - E542
  • [10] Surgery and Survival of Patients with Diagnosis of Malignant Pleural Mesothelioma
    Carbonelli, Cristiano
    Rapicetta, Cristian
    Cesario, Alfredo
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : E92 - E93